These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31023428)

  • 21. Glycaemic variation is a predictor of all-cause mortality in the Veteran Affairs Diabetes Trial.
    Zhou JJ; Koska J; Bahn G; Reaven P
    Diab Vasc Dis Res; 2019 Mar; 16(2):178-185. PubMed ID: 31014099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postprandial glucose monitoring further improved glycemia, lipids, and weight in persons with type 2 diabetes mellitus who had already reached hemoglobin A1c goal.
    Zhang DA; Katznelson L; Li M
    J Diabetes Sci Technol; 2012 Mar; 6(2):289-93. PubMed ID: 22538137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of prompt revascularization on outcomes in diabetic patients with stable ischemic heart disease and previous myocardial infarction in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Chung MJ; Novak E; Brown DL
    Coron Artery Dis; 2017 Jun; 28(4):301-306. PubMed ID: 28346285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy.
    Riedel AA; Heien H; Wogen J; Plauschinat CA
    Pharmacotherapy; 2007 Aug; 27(8):1102-10. PubMed ID: 17655510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model.
    Pantalone KM; Misra-Hebert AD; Hobbs TM; Kong SX; Ji X; Ganguly R; Milinovich A; Weng W; Bauman JM; Petraro P; Burguera B; Zimmerman RS; Kattan MW
    Diabetes Care; 2020 Aug; 43(8):1910-1919. PubMed ID: 32527797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.
    Halperin F; Ding SA; Simonson DC; Panosian J; Goebel-Fabbri A; Wewalka M; Hamdy O; Abrahamson M; Clancy K; Foster K; Lautz D; Vernon A; Goldfine AB
    JAMA Surg; 2014 Jul; 149(7):716-26. PubMed ID: 24899464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemoglobin A1C testing frequency among patients with type 2 diabetes within a US payer system: a retrospective observational study.
    Weiss T; Edwards A; Lautsch D; Rajpathak S; Snow K
    Curr Med Res Opin; 2021 Nov; 37(11):1859-1866. PubMed ID: 34402701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Tailored Cognitive-Behavioural Intervention Produces Comparable Reductions in Regimen-Related Distress in Adults With Type 2 Diabetes Regardless of Insulin Use: 12-Month Outcomes From the COMRADE Trial.
    Lutes LD; Cummings DM; Littlewood K; Le MT; Kirian K; Patil S; Solar C; Carraway M; Hambidge B
    Can J Diabetes; 2020 Aug; 44(6):530-536. PubMed ID: 32792107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between degree of risk factor control and all-cause mortality in individuals with type 2 diabetes: A prospective cohort study.
    Garofolo M; Penno G; Solini A; Orsi E; Vitale M; Resi V; Bonora E; Fondelli C; Trevisan R; Vedovato M; Nicolucci A; Pugliese G;
    Eur J Intern Med; 2024 Oct; 128():53-62. PubMed ID: 38845288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.
    Rawshani A; Rawshani A; Sattar N; Franzén S; McGuire DK; Eliasson B; Svensson AM; Zethelius B; Miftaraj M; Rosengren A; Gudbjörnsdottir S
    Circulation; 2019 Apr; 139(16):1900-1912. PubMed ID: 30798638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease.
    Weintraub WS; Hartigan PM; Mancini GBJ; Teo KK; Maron DJ; Spertus JA; Chaitman BR; Shaw LJ; Berman D; Boden WE
    Circ Cardiovasc Qual Outcomes; 2019 Feb; 12(2):e005079. PubMed ID: 30773025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A
    Tian J; Ohkuma T; Cooper M; Harrap S; Mancia G; Poulter N; Wang JG; Zoungas S; Woodward M; Chalmers J
    Diabetes Care; 2020 Jun; 43(6):1293-1299. PubMed ID: 32193249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes.
    Shah DD; Fonarow GC; Horwich TB
    J Card Fail; 2010 Mar; 16(3):200-6. PubMed ID: 20206893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High hemoglobin A
    Arya S; Binney ZO; Khakharia A; Long CA; Brewster LP; Wilson PW; Jordan WD; Duwayri Y
    J Vasc Surg; 2018 Jan; 67(1):217-228.e1. PubMed ID: 28844470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis.
    Gaebler JA; Soto-Campos G; Alperin P; Cohen M; Blickensderfer A; Wintle M; Maggs D; Hoogwerf B; Han J; Pencek R; Peskin B
    Vasc Health Risk Manag; 2012; 8():255-64. PubMed ID: 22566747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.
    Riddle MC; Ambrosius WT; Brillon DJ; Buse JB; Byington RP; Cohen RM; Goff DC; Malozowski S; Margolis KL; Probstfield JL; Schnall A; Seaquist ER;
    Diabetes Care; 2010 May; 33(5):983-90. PubMed ID: 20427682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychological distress, glycated hemoglobin, and mortality in adults with and without diabetes.
    Hamer M; Stamatakis E; Kivimäki M; Pascal Kengne A; Batty GD
    Psychosom Med; 2010 Nov; 72(9):882-6. PubMed ID: 20884891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lifestyle Interventions in Diabetes and Coronary Disease: A Timely Reminder.
    Farkouh ME; Godoy LC
    J Am Coll Cardiol; 2019 Apr; 73(16):2059-2061. PubMed ID: 31023429
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk factor management in stable, insulin-treated patients with Type 2 diabetes: the Diabetes Outcomes in Veterans Study.
    Murata GH; Shah JH; Wendel CS; Hoffman RM; Adam KD; Bokhari SU; Solvas PA; Duckworth WC
    J Diabetes Complications; 2003; 17(4):186-91. PubMed ID: 12810241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.